| Literature DB >> 27169821 |
Mahesh Ramalingam1, Sung-Jin Kim1.
Abstract
Liriopogons (Liriope and Opiopogon) species are used as a main medicinal ingredient in several Asian countries. The Liriopes Radix (tuber, root of Liriope platyphylla) has to be a promising candidate due to their source of phytochemicals. Steroidal saponins and their glycosides, phenolic compounds, secondary metabolites are considered of active constituents in Liriopes Radix. Spicatoside A, a steroidal saponin, could be more efficacious drug candidate in future. In this review, we summarized the available knowledge on phytochemical and pharmacological activities for spicatoside A. It significantly suppressed the level of NF-κB, NO, iNOS, Cox-2, IL-1β, IL-6 and MAPKs in LPS-stimulated inflammation. The production of MUC5AC mucin was increased. MMP- 13 expression was down-regulated in IL-1β-treated cells and reduced glycosaminoglycan release from IL-1α-treated cells. The neurite outgrowth activity, PI3K, Akt, ERK1/2, TrkA and CREB phosphorylation and neurotropic factors such as NGF and BDNF were upregulated with increased latency time. It also showed cell growth inhibitory activity on various carcinoma cells. From this, spicatoside A exerts anti-inflammation, anti-asthma, anti-osteoclastogenesis, neurite outgrowth, memory consolidation and anticancer activities. Further studies are needed on spicatoside A in order to understand mechanisms of action to treat various human diseases.Entities:
Keywords: Anti-inflammatory; L. platypylla; Liriopes; Memory consolidation; Neurite outgrowth; Saponins
Year: 2016 PMID: 27169821 PMCID: PMC5012870 DOI: 10.4062/biomolther.2015.214
Source DB: PubMed Journal: Biomol Ther (Seoul) ISSN: 1976-9148 Impact factor: 4.634
Fig. 1.The structure of spicatoside A.
Major pharmacological activities reported for spicatoside A
| Pharmacological activities | Active dose | References |
|---|---|---|
| Anti-inflammatory activities in RAW264.7 macrophage cells | 10, 50 and 100 µM | |
| Anti-asthma activities in NCI-H292 airway epithelial cells | 100, 10 and 1 nM | |
| Anti-osteoclastogenesis activities in SW1353 human chondrocyte cells | 0.5 to 5 µM | |
| Neurite outgrowth activities in undifferentiated PC12 cells | 1, 5 and 10 µM | |
| Memory consolidation activities in mice | 2.5, 5, 10 and 20 mg/kg | |
| Anti-cancer activities in A549, SK-OC-3, SK-Mel-2, XF-498 and HCT-15 cancer cells | 5, 10, 50 and 100 µg/ml |